"...we will report on the outcomes of the consultation process in the June quarter" That's in the Feb half year report where they are discussing the Zeiss product. "
"Implementation is largely complete and should lead to completion of product for MRS in the June quarter. "
As Optiscan has the role of OEM and MR Solutions the role of distributor, MR Solutions would hold the inventory. Some demo units and a bit of stock would make for some nice initial sales.
As soon as we hear that product is being sold the share price should lift.
http://www.axt.com.au/wp-content/uploads/2015/02/AXT_Preclinical_Product_Guide_2015.pdf
"...we will report on the outcomes of the consultation process...
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.005(2.17%) |
Mkt cap ! $183.7M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.0¢ | $32.22K | 143.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 89636 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 93164 | 2 |
View Market Depth
| Last trade - 11.15am 11/07/2024 (20 minute delay) ? |
| OIL (ASX) Chart |